Home   Contact   Partners

Vermillion


Multi-biomarker approach for associations between genes, proteins and diseases


Originally known as Ciphergen Biosystems, Inc., Vermillion was founded in 1993.


Gail S. Page (President & CEO)
Eric Fung, M.D., Ph.D. (Vice President, CSO)
Debra A. Young (Vice President, CFO)


James L. Rathmann (Chairman)
John A. Young
Gail S. Page
Judy Bruner
James S Burns
Michael J. Callaghan
Kenneth J. Conway
Rajen K Dala


6611 Dumbarton Circle
Fremont, CA 94555
USA
Phone: +1-510-505-2100
Fax: +1-510-505-2101


Vermillion uses a multi-biomarker approach in order to identify associations between genes, proteins and diseases that translate into meaningful information about disease states.
This information will then be used to create and market high-value diagnostic tests with sufficient sensitivity and specificity to aid physicians in predicting disease risk, selecting appropriate therapies, monitoring disease progression and improving outcomes for patients.

Related patents